#Cattle Respiratory Vaccines Market Trends | Explore Tumblr Posts and Blogs

pharmaceuticals88 · 2 years

Text

Cattle Respiratory Vaccines Market 2022 Industry Size, Share, Trend Technology, Global Key Players | 2029

The Cattle Respiratory Vaccines Market Market Size At USD by 2029, exhibiting a CAGR of 6.4% during 2022-2029

Cattle Respiratory Vaccines Market Overview

The Cattle Respiratory Vaccines Market report is a comprehensive overview of the market, including a review of its major segments. Alliances are developed after thorough primary and secondary studies. By speaking with industry experts and collecting their data, in-depth market data is produced. The report provides a thorough account of many market factors, including trends, segmentation, growth prospects, chances, difficulties, and competitive analyses.

Get a Sample copy of the report:

List of Key Players Of Cattle Respiratory Vaccines Market Report:

Zoetis, Boehringer Ingelheim,, Novartis, Agri Labs, Merck, exas Vet Labs,

Key Segments Covered in Cattle Respiratory Vaccines Market

By Type, it is segmented into

Infectious Bovine Rhinotracheitis (IBR) Vaccine

Bovine Viral Diarrhea (BVD) Vaccine

Parainfluenza 3 (PI3) Vaccine

Bovine Respiratory Syncytial Virus (BRSV) Vaccine

By Application, it is segmented into

Government Tender

Mark

Competitive Landscape

Cattle Respiratory Vaccines Market are showing an increasing amount of interest in creating unique products. In addition, several companies are collaborating, merging, and acquiring one another. In the upcoming years, all of these initiatives are anticipated to drive the global Cattle Respiratory Vaccines Market to new heights.

The Cattle Respiratory Vaccines Market Regional Analysis Covers

– North America: United States, Canada, and Mexico. – South & Central America: Argentina, Chile, and Brazil. – Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa. – Europe: UK, France, Italy, Germany, Spain, and Russia. – Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.

Get in Touch with Us: - Phone No.+1 (704) 266-3234

Mail to: [email protected]

#Cattle Respiratory Vaccines Market Research #Cattle Respiratory Vaccines Market Forecast #Cattle Respiratory Vaccines Market Size #Cattle Respiratory Vaccines Market Share #Cattle Respiratory Vaccines Market Trends #Cattle Respiratory Vaccines Market Overview

0 notes

jayanthitbrc · 9 months

Text

Global Veterinary Anti-infectives Market Analysis 2024 – Estimated Market Size And Key Drivers

The Veterinary Anti-infectives by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Veterinary Anti-infectives Market: https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

According to The Business Research Company’s Veterinary Anti-infectives, The veterinary anti-infectives market size has grown strongly in recent years. It will grow from $5.09 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing pet ownership, prevalence of infectious diseases, advancements in veterinary medicine, rising awareness, government initiatives.

The veterinary anti-infectives market size is expected to see strong growth in the next few years. It will grow to $8.05 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to continued pet population growth, emerging zoonotic diseases, globalization of pet trade, increasing veterinary healthcare expenditure. Major trends in the forecast period include technological advancements, increasing adoption of biologicals, integration of telehealth in veterinary services, focus on natural and herbal alternatives, expansion of e-commerce in veterinary pharmaceuticals, collaborations and partnerships.

An increase in pet ownership is expected to propel the growth of the veterinary anti-infectives market going forward. Pet ownership refers to owning a dog, cat, or other domestic pet at home. Pet are being adopted as increasing number of the young population are considering them as part of their family, some owners are adopting them for their compassion, loyalty and the to prevent loneliness. For instance, in February 2023, according to Chewy Inc., a US-based online retailer of pet food and other pet-related products, in 2021, approximately 977,202 pets found homes through adoption in the United States, marking the highest adoption rate in the past six years at 61%. Therefore, an increase in pet ownership is driving the demand for veterinary anti-infectives market.

Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes 2) By Species Type: Livestock Animals, Companion Animals 3) By Mode Of Administration: Oral, Parenteral, Topical 4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Technological advancements are a key trend gaining popularity in the veterinary anti-infectives market. Major companies operating in the market are using advanced technologies to sustain their position in the veterinary anti-infectives market. For instance, in February 2021, Elanco Animal Health Incorporated, a US-based pharmaceutical company that manufactures drugs and vaccinations for pets and livestock launched Increxxa, the newly approved drug for livestock respiratory disease. Increxxa with its key ingredient being tulathromycin is delivered to the livestock in injection and targets the lungs' site of infection swiftly for fast action and a lengthy half-life, providing cattle more time to establish a strong defense. This product is designed for veterinary use and tulathromycin, the active ingredient in Increxxa, helps decrease the negative effects of bovine respiratory disease.

The veterinary anti-infectives market report table of contents includes:

Executive Summary

Market Characteristics

Market Trends And Strategies

Impact Of COVID-19

Market Size And Growth

Segmentation

Regional And Country Analysis . . .

Competitive Landscape And Company Profiles

Key Mergers And Acquisitions

Future Outlook and Potential Analysis

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: [email protected]

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

0 notes

decisionforsight · 3 years

Text

Global Bovine Respiratory Disease Treatment Market

Global Bovine Respiratory Disease Treatment Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

Bovine respiratory disease (BRD) is the most common and costly disease attacking beef cattle in the world. It is a complex, bacterial infection that causes pneumonia in calves which can be fatal. Symptoms including such as high fever, nasal discharge, rapid and shallow breathing, coughing, diminished, or no appetite. It is not a contagious disease. For the treatment of the BRD, vaccines are available. The most commonly used vaccine for veterinary respiratory diseases is antimicrobial agents, Non-steroidal anti-inflammatory drugs (NSAIDs), mucolytic agents. Oral rehydration, fluids, Bronchodilators, and immunomodulators. The global bovine respiratory disease treatment market size valued USD 449 million in 2020 is expected to reach USD 3279.78 million growing with a CAGR of 22 % over the forecast period.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020209

Market Dynamics and Factors:

According to the study, the increasing consumption of beef and the rising population are the major factors that are driving the bovine respiratory disease treatment market. The increase in beef consumption is due to the rising population and increasing disposable income, across the globe. Bovine Respiratory Disease (BRD) has a negative impact on the dairy and beef industries, due to calf mortality, treatment expenses, and additional labor costs. Additionally, BRD adversely affects the reproductive performance, growth, and lifespan of cattle. Consequently, there is a huge necessity for bovine respiratory disease treatment market. Moreover, to meet, the increasing demand for beef, most of the countries in the world are expanding the production of cattle meat. The rising demand for beef, increased production, leads to the growing importance of bovine respiratory disease treatment market. There are certain difficulties that are associated with the diagnosis of the BRD. Animals suffering from BRD often show signs of depression, weight loss, cough, nasal discharge, high fever, increased respiratory rate, and abnormal pulmonary sound on auscultation. The presumptive diagnosis after a physical examination is difficult, owing to the similarities of clinical signs and variation of possible bacteria. Hence, the complex diagnostic procedure is controlled the bovine respiratory disease treatment market growth.

Market Segmentation:

Global Bovine Respiratory Disease Treatment Market – By Drug Type

Antibiotics

Vaccines

NSAIDs

Immunomodulators

Others

Global Bovine Respiratory Disease Treatment Market – By Disease Type

Upper Respiratory Tract Infections

Pneumonia

Diphtheria

Global Bovine Respiratory Disease Treatment Market – By Distribution Channel

Veterinary Hospitals

Veterinary Clinics

Private Veterinary Pharmacies

Veterinary Research Institutes

Online Pharmacies

Global Bovine Respiratory Disease Treatment Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020209

Geographic Analysis:

Among the regions, North America is dominated the market in 2019 by contributing the largest bovine respiratory disease treatment market share in terms of revenue, due to increasing awareness about diseases and its treatment, high consumption of beef, increasing production and export beef, and the presence of companies available for manufacturing vaccines for bovine respiratory diseases. Asia Pacific is anticipated to grow at a higher CAGR Around 8.2% during the forecast period. Because of the growing population in India and China.

Competitive Scenario:

The market key players operating in the bovine respiratory disease treatment industry are Bayer Corporation, Boehringer Ingelheim GmbH, Bimeda Animal Health, Elanco, Vetoquinol S.A., Merck & Co Inc., Zoetis Inc., Novartis Animal Health, Vibrac S.A., Ceva Sante Animale, and Bimeda Animal Health.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020209

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Bovine Respiratory Disease Treatment industry, although key threats, opportunities and disruptive technologies that could shape the Global Bovine Respiratory Disease Treatment Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Bovine Respiratory Disease Treatment Market most.

The data analysis present in the Global Bovine Respiratory Disease Treatment Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Bovine Respiratory Disease Treatment Market business.

The 2021 Annual Global Bovine Respiratory Disease Treatment Market offers:

100+ charts exploring and analysing the Global Bovine Respiratory Disease Treatment Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Bovine Respiratory Disease Treatment Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020209

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: [email protected]

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

0 notes

vinayakmrfr1998-blog · 4 years

Text

Animal Health Market Size, Growth, Trends, Regional Factors and Analysis Under Global Industrial Research Forecast Till 2023

Animal Health Market: Information by Animal Type (Farm animal, Companion animal), Product (Pharmaceuticals, Vaccines, Feed Additives), Route of Administration (Oral, Parenteral), Distribution Channel (Retail, E-Commerce) — Global Forecast till 2023

Animal health is a branch of medicine catering to the welfare of companion and farm animals. It is vital in preventing the propagation of infectious diseases to animals, which in turn can affect humans. Continuous monitoring of animals is a prime aspect of animal health. The global animal health market report by Market Research Future (MRFR) contains an analytical perspective on numerous trends, opportunities, drivers, and restraints to be faced by manufacturers creating medicines and drugs for the period of 2018 to 2023 (forecast period).

Market Scope

The global animal health market is projected to exhibit 5.7% over the forecast period. It can be driven by the outbreak of infectious diseases affecting animals in recent years. For instance, porcine reproductive and respiratory syndrome (PRRS) had costs farmers in the U.S. close to USD 600 million. Deterioration of animal health can negatively economic growth of nations and overall stability of the agricultural sector. The market had stood at a value of USD 38,500 million in 2017.

Free Sample Report At:

https://www.marketresearchfuture.com/sample_request/7163

Rise of zoonotic diseases, inflated spending on animal health, rising adoption numbers of pets, and growing pet insurance are major factors expected to drive market growth. Scientists suggest that 6 out of 10 infectious diseases affecting humans have the probability of coming from animals, according to the Center of Disease Control & Prevention (CDC). Government programs supporting veterinarians, scientists, and farmers in their fight against tackling infectious diseases is expected to work favorably for the market.

But high costs associated with animal health and lack of veterinary services in underdeveloped services can hamper market growth.

Segmentation

The global animal health market is segmented by animal type, product, route of administration, and distribution channel.

By animal type, the market caters to farm animal and companion animal. The farm animal segment has been further segmented into sheep & goats, poultry, swine, cattle, and others. While the companion animal segment has been further classified into equine, dog, cat, and others. Among the two, the farm animal segment is expected to hold the largest market share of the animal health market till the end of the forecast period.

Products include feed additives, pharmaceuticals, and vaccines. Pharmaceuticals are further sub-segmented into anti-inflammatory, parasiticides, anti-infectives, analgesics, and others. While, the vaccines segment is further split into recombinant vaccines, live attenuated vaccines, inactivated vaccines, DNA vaccines, and others. The vaccines segment to register the highest CAGR in the global animal health market during the forecast period.

Based on route of administration, the market has been segmented into topical, oral, parenteral, and others.

Distribution channels discussed in the global animal health market include e-commerce, veterinary hospitals & clinics, retail, and others.

Regional Analysis

Geographically, the market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas can dominate the global animal health market till 2024 owing to heightened demand for advanced veterinary services. Focus on animal safety, demand for animal protein, medication of pets, and adoptions of pets from shelters are major drivers of the market. According to the American Pet Products Manufacturing Association (APPA), nearly 80% of pets in the U.S. are treated with drugs.

APAC is projected to display the fastest growth rate during the forecast period owing to rise in animal welfare programs and the growth in the population of animal welfare programs. India and China are countries expected to contribute to regional market growth.

Competitive Outlook

Eli Lilly, Virbac, Zoetis, Elanco, Vetiquinol SA, Merck Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, Bayer AG, and Nutreco N.V. are top animal health companies profiled in the market report. Players are focusing on innovations which can expand the scope of the future of animal health.

Browser Complete Report At:

https://www.marketresearchfuture.com/reports/animal-health-market-7163

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

#Animal Health Market #Animal Health Market Growth #Animal Health Market Trends #Animal Health Market Research #Animal Health Market Size #Animal Health Market Share

0 notes

quicklovesolutions-blog · 5 years

Text

Things to Know About Coronavirus, Its Symptoms And Its Prevention

Coronavirus is a group of viruses mainly found in mammals which includes Human also and it became the trending topic for NEWS headlines as many people are getting infected by this virus and hundreds of people from different countries has already lost their lives. China has got huge impact because of this virus, people are getting locked to their homes and buildings by the officials just not to spread this virus. People who are infected by this virus are not allowed to visit their families even doctors who are involve in the rescue operations has also lost their life. People from other countries who went to china for some reasons, are appealing to their respective governments to accept them back to their country. But, as this virus spread very easily and due to lack of treatment available in the world, countries are hesitating to bring the citizen back. The most important fact about this is till now no vaccine or exact treatment available to overcome this dangerous virus. In this articles I am going to share few facts about this virus.

This virus mainly found in mammals which includes Human and birds as well. It mainly found in animals such as cows, pigs and chickens and the animal carrying Coronavirus shows symptoms like diarrhea and upper respiratory diseases and there is no drug or vaccine available for its prevention.

Facts:

SARS and MERS are the two dangerous disease that can be caused by Coronavirus. In research, it is found that this virus can infect mice, rats, dogs, cats, pigs and cattles. This viruses are responsible for about 30% of common colds and there are six known human coronaviruses. SARS (Sever acute respiratory syndrome) spread from China to other nearby countries like Singapore and killed almost 774 or more peoples. There is no vaccine available for the common cold by Coronavirus. Human Coronavirus

Human Coronavirus first found in 1960's in the noses of patient with common cold.

Coronavirus were given their name because of its crown like projection on its surface and corona in "Latin" means "Halo" or "Crown".

Coronavirus antibodies do not last for a very long time. In humans, this infection most often occurs during the month of winters as well as rainy.

Symptoms

Human infected with this virus can be found with the following symptoms.

Cold or flu type symptoms Fever Running nose Sneezing Sore throat Fatigue Asthma Any respiratory disorder Things to be taken care

As these virus has no particular vaccine or drug available in the market following things has to be taken care of so to prevent these virus from spreading.

Drink enough water (boiled) Avoid smoking Avoid going to public places, if necessary then carry mask Use clean cloth to stop running nose or while sneezing Take rest and avoid overexertion If found any symptomes then consult direct to the doctor If you traveled recently internationally and find any symptoms then consult your doctor and tell then about this before visiting them. As always said, prevention is better than cure, so we need to be aware about such health problems. I wish all of you to be aware and stay healthy.

vashikaran for husband

black magic specialist

relationship problem solution

best vashikaran specialist astrologer

best tantrik

other caste love marriage specialist baba

muslim love vashikaran

kala jadu vashikaran

vashikaran for girl

vashikaran for wife

vashikaran mantra

vashikaran specialist

love marriage specialist

get your love back

divorce problem solution

online vashikaran

love problem solution

husband wife problem solution

vashikaran for boy

family problem solution

vashikaran specialist in delhi

famous astrologer in India

real vashikaran specialist

sabar mantra specialist

true vashikaran specialist

vashikaran astrologer

vashikaran baba

vashikaran specialist near me

vashikaran tantrik

Love Problem Solution in Delhi

Love Problem Solution in Mumbai

Love Problem Solution in Bangalore

Love Problem Solution in Pune

Love Problem Solution in Hyderabad

Love Problem Solution in Bhopal

Love Problem Solution in Kolkata

Love Problem Solution in Bhubaneswar

Love Problem Solution in Guwahati

Love Problem Solution in Lucknow

#love problem solution #best astrologer #vashikaran specialist #mohini mantra specialist #red book specialist #gem stones specialist #black magic specialist

0 notes

healthcareandwellness-blog · 6 years

Link

Veterinary Vaccines Market: Introduction

Veterinary vaccines increase immunity among animals by improving their health which further avoids the transmission of various diseases from animals to humans. Veterinary vaccines can be given in many ways such as subcutaneously or intramuscularly to the animals. The primary aim of these veterinary vaccines is to improve the animal production in a cost-effective manner. Rising incidences of various zoonotic diseases will affect the humans, and this has led to the increased interest in various animal vaccines. Recent advancements in the development of vaccines to improve immunity will significantly drive the veterinary vaccines market over the projected period.

Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/236

Market Dynamics

Rapid growth in population preferring companion animals globally is one of the major factors favoring the veterinary vaccines market growth. Increasing awareness regarding the vaccination programs by various regulatory bodies will further drive the global veterinary vaccines market over the projected period. The market is further anticipated to witness a considerable revenue growth over the projected period, owing to increasing incidences of various food-borne zoonotic diseases across the globe. Moreover, significant rise in white meat demand in regions such as North America and Europe will in turn support the growth of veterinary vaccines market in the coming future.

Anthrax is one of the common animal diseases across the globe. According to World Health Organization, although many national programs have improved the control of anthrax, the disease is still prevalent, majorly due to the lack of experience among recent veterinarians, in order to identify and analyze the disease. From January to April 2015, various disease reports from countries in some parts of the Middle East, North and West Africa, and in some parts of Asia included foot-and-mouth disease (FMD) along with H5N1 HPAI outbreaks significantly, attracted various organizations across the globe. This has driven the demand for veterinary vaccines across the globe in that period.

By Vaccine Type

Attenuated live veterinary vaccines is expected to have the largest market share over the projected period. This is one of the oldest vaccination methods used for veterinary sector. This vaccination method is also used as a trial for developing additional applications of animal vaccines.

By Animal Type

Veterinary vaccines market for cattle is predicted to hold the largest share over the projected period. Rising livestock population, couple with tightening government initiatives to reduce the disease outbreaks among cattle are the key factors driving the global veterinary vaccines market over the projected period. Recent outbreaks of some key viral respiratory infections among cattle will further push the veterinary vaccines market growth.

Regional Insights

North America veterinary vaccines market is expected to dominate the global market throughout the projected period. Increasing incidences of various canine disorders is accelerating the adoption of various vaccines for animals. Moreover, rising pets among the population of the U.S. will further contribute to the growth of North America veterinary vaccines market over the projected period.

Europe veterinary vaccines market is expected to hold the second largest market share after North America. Increasing animal husbandry practices, coupled with higher pet population will propel the growth of veterinary vaccines market in this region.

Competitive Landscape

Some of the key players in the global veterinary vaccines market include Virbac Inc., Zoetis, Heska Corp., Indian Immunological Limited, Bayer Pharma AG, Boehringer Inghlem, Biogenesis Bago, and Merck Animal Health among several others.

For more information about this report @ https://www.insightsandreports.com/industry-reports/veterinary-vaccines-market

#Global Veterinary Vaccines Market #Veterinary Vaccines Market #Veterinary Vaccines Market Research #Veterinary Vaccines Market Report #Veterinary Vaccines Market Development #Veterinary Vaccines Market Analysis #Veterinary Vaccines Market Overview #Veterinary Vaccines Market Demand #Veterinary Vaccines Market Growth

0 notes

ahila-blog1 · 6 years

Text

Global Veterinary Anti-infectives Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Anti-infectives are the substances which have the ability to counter the malfunction caused by foreign bacteria, fungi, virus, parasites, and among others. Anti-infectives are used to prevent or completely cure of various infectious diseases. These substances prevent the chances of contracting the infection by making the body immune from the specific bacterial infection. Commonly occurred veterinary infectious diseases include zoonotic diseases and foodborne disorders.

Increase in the global animal adoption rate, a rise in the prevalence of foodborne and zoonotic diseases, increase in the R&D activities for innovation of new products, and government initiations for the animal healthcare are anticipated to fuel the veterinary anti-infectives market. Moreover, increase in the preference for healthy meat and other dairy products, a rise in awareness about the animal infectious diseases, lack of awareness about veterinary vaccines, and growing animal healthcare expenditure expected to boost the veterinary anti-infectives market over the forecast period. However, stringent regulatory policies for veterinary medicines and lack of awareness about the anti-infective drugs in underdeveloped regions might hinder the growth of veterinary anti-infectives market.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-veterinary-anti-infectives-market/#ulp-4H8Z4LpNMLEuOnnx

Veterinary anti-infectives market is segmented on the basis of drug type, disease type, species type, route of administration and end user

Based on the drug type, veterinary anti-infectives market is segmented into the following:

· Anti-viral drugs

· Anti-bacterial drugs

· Parasiticides

· Anti-fungal drugs

· Others

Based on the disease type, veterinary anti-infectives market is segmented into the following:

· Dermatological infections

· Respiratory infections

· Gastrointestinal infections

· Ophthalmic infections

· Others

Based on the species type, veterinary anti-infectives market is segmented into the following:

· Farm animals

o Cattle

o Aqua

o Swine

o Sheep

o Poultry

o Others

· Companion animals

o Canines

o Felines

o Horses

o Rabbits

o Others

Based on the route of administration, veterinary anti-infectives market is segmented into the following:

· Oral

· Parenteral

· Topical

· Others

Based on the distribution channel, veterinary anti-infectives market is segmented into the following:

· Veterinary hospitals

· Veterinary pharmacies

· Online pharmacies

· Others

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-veterinary-anti-infectives-market/#ulp-c654SbFYO64MsOhu

The veterinary anti-invectives market is growing at a significant CAGR owing to increase in the animal adoption rate. Market players are actively focusing on the development of novel medicines and vaccines for the prevention or cure of various infectious diseases in animals. The rise in the prevalence of foodborne and zoonotic diseases also expected to propel the veterinary anti-infectives market over the forecast period. Acquisitions and mergers, collaborations, product innovations, and launchings are the strategies followed by the companies for garnering market revenue share in the global veterinary anti-infectives market. For instance, in January 2013, Bayer healthcare acquired Teva’s animal healthcare business including the veterinary anti-infectives for diversifying its veterinary anti-infectives product portfolio. Moreover, In May 2013, Novabay Pharmaceuticals inked a collaboration agreement with Virbac for exploring uses of veterinary anti-infective drug auriclosene.

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-veterinary-anti-infectives-market/#ulp-14mlyhjMGhVjZqa3

Geographically, veterinary anti-infectives market is segmented into Europe, Asia Pacific, Latin America, North America, and the Middle East and Africa. Increase in the pet animal adoption rate, a rise in animal welfare, growing R&D activities for innovation of novel products, and rise in per capita income are the factors anticipated to fuel the veterinary anti-infectives market in North America region. Europe holds a significant share in the veterinary anti-infectives market owing to rise in prevalence of zoonotic and foodborne diseases, innovation of newer products, a rise in awareness the animal welfare, and animal healthcare expenditure are anticipated to fuel the market in the region. However, the Asia Pacific region has a significant growth over the forecast period due to rise in the rearing of farm animals majorly in India and China, increase in the preference for healthy meat and other dairy products, and rise in the prevalence of infectious diseases are anticipated to fuel the veterinary anti-infectives market.

Some of the players in veterinary anti-infectives market are Zoetis, Inc. (Pfizer) (U.S), Virbac AH Inc. (France), Sanofi S.A. (France), Boehringer Ingelheim Vetmedica, Inc. (Boehringer Ingelheim) (Germany), Bayer HealthCare LLC, (Bayer AG) (Germany), Merck Animal Health (Merck &co. Inc.) (U.S.), Dechra Pharmaceuticals (U.K.), and NovaBay Pharmaceuticals, Inc. (U.S.) to name a few.

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-veterinary-anti-infectives-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: [email protected]

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

#Veterinary Anti-infectives Market

0 notes

marketdataforecastblog-blog · 7 years

Text

Animal Healthcare Market – A Scottish View

Scotland Animal Healthcare Market – Overview

The Kansa City Animal Health Corridor is quite well known among those keeping a tab on the animal health care market. The Kansas corridor is the epicenter of all the organizations related to healthcare in North America, accounting for greater than 80 percent of the revenue generated in animal healthcare in North America annually. The corridor functions by providing the interested stake holders with a common ground for interaction and collaboration with top notch market/industry leaders which aids in the growth of the company. The above is an example from North America, but on the same lines, similar developments are taking place in the country of Scotland to translate it into a hub of healthcare for animals in Europe.

The building blocks to help make Scotland the ideal center for aquaculture research and animal healthcare have already been laid. The demographics of the country also aid in the process as about 50 percent of the spending on veterinary healthcare of the United Kingdom if being offered to Scotland. Furthermore, the ample availability of natural for the prospering of the industry is one of the major factors for the choice of Scotland to be established as the European epicenter for veterinary health care. The Roslin Institute has helped in generating annual profits of more than £250 million in the arenas of genetic and breeding research. Also, there are more than a thousand researchers in the country working on the innovation of the veterinary healthcare industry. Vaccines used for the immunization of respiratory problems in sheep and cattle were first created in Scotland. The high availability of skilled labor, good infrastructure and rapid innovation in R&D are the major factors, which, coupled with the steps being taken by the Scottish government, are expected to yield positive results in establishing Scotland as the hub for animal health care in Europe.

There are quite a number of world renowned companies in the animal healthcare industry in Scotland. The Fish Vet Group, which is a subsidiary of Benchmark Holdings, is one of them. The Fish Vet Group has begun operations on a fish farm in the coastal areas of Scotland and has now robustly expanded into a global leader of health services for aquatic animals. Favorable demographics offered by the country have surely aided the company in its journey onward to become a global leader in the market. Furthermore, Veterinary diagnostics, healthcare, and environmental aspect control are among a few services offered by the company. Recently, the company was in the news for the launch of its operations in Thailand, which is one of the largest aquaculture markets on the planet. Top notch researchers are being attracted to work for the company to innovate and further its operations. The world renowned Salmonid Specialist Dr. Marian McLoughlin, is among the latest minds to join the company, which speaks a lot about the brand of the company. The company also acquired Vet Aqua International, which is an Ireland based company, which has further established their position in the market. The company’s presence has now expanded to Ireland, Thailand, Norway, and the USA, all of which are seasoned markets which will undoubtedly aid the company in furthering its ambitions.

One of the major factors which aided the global growth of The Fish Vet Group was the very supportive government policies which provided the required resources for the company to grow and even acquire other market players. Keeping in mind the increasing demand pressures in the veterinary healthcare market it can be concluded that Scotland is one of the growing hotspots of animal health care in the world. The case study of The Fish Vet group can act as example for other market players to launch their business operations in the country.

Check out Market Data Forecast’s comprehensive reports with in-depth analysis about the Europe Veterinary Healthcare Market a free research sample can also be availed. Stay tuned for trending news stories about the latest technologies and interesting Healthcare tit-bits.

#animal healthcare

0 notes

healthy-insights · 7 years

Text

Cattle Biologics Manufacturing Market Growth, Trends and Forecast up to 2020

Cattle biologics are defined as the vaccines, bacterins, diagnostics etc which helps to prevent, diagnose or treat the disease conditions in cattle and calves. These product works through some immunological pathway. The Cattle Biologics Manufacturing Market consist of four major segments on the basis of the products namely Vaccines, Pre-breeding vaccines for calves, Antibodies, Diagnostic kits.

Among these categories, vaccines and pre-breeding vaccines for calves capture the major share of the market. Vaccines are provided to both cattle and calves, especially the new born calves to save them from various diseases such as clostridial diseases, anthrax, bovine virus diarrhea and vibriosis. On the basis of type of manufacturing the cattle biologics manufacturing market is divided into four main categories which includes Bacterins, Bacterin Toxoid, Non-bacterins, Custom made Vaccines.

Bacterins include vaccines which are made from killed bacteria, while the bacterin toxoids include vaccines which are made from live bacteria. In cattle vaccination, bacterin toxoid is preferred over other vaccination due to its long lasting effect. Texas Vet Lab, Inc. is one of the major market players of bacterins and bacterin toxoid and it is offering a wide range of products in its portfolio such as moraxella ovis, unique serovars of Salmonella and Histophilus Somni. Custom-made vaccines are also capturing a major part of the cattle biologics manufacturing market and have been complement to “off-the-shell” products in the U.S. market. Custom-made vaccines are the vaccines which are manufactured from the specific virus or bacteria which is major cause of disease in livestock operation. Newport Laboratories is one of the market players which is offering custom-made vaccines to the producers and veterinarians which gives them option to prepare a mixture of different products, modified according to producer that is not commercially available.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3608

Pre-breeding vaccination includes the vaccines, which are given to calves at the age between 12 months to 15 months. These vaccines are provided to calves to protect them against common reproductive diseases. On the basis of the vaccines which are provided to the calves, cattle biologics manufacturing market is divided into six major classes are Bovine Viral Diarrhea (BVD), Infectious Bovine Rhinotracheitis (IBR), Leptospirosis, Bovine respiratory syncytial virus (BRSV), Clostridium, Trichomoniasis.

Among these the bovine viral diarrhea is most commonly used vaccine followed by leptospirosis and trichomoniasis. All these pre-breeding vaccinations protect calves from delayed breeding, smaller calves, potential abortions and persistently infected calves.

North America and Europe currently lead the cattle biologics manufacturing market majorly due to strong economic conditions and large number of cattle population. The major market of Europe is driven by Switzerland, which is known for cows and cattle. In 2010, there were 1,591, 233 cattle in Switzerland. Additionally, the government of U.S. and Europe has also setup some regulatory firms which are also helping the market to grow. As in Canada, the Canadian Food Inspection Agency (CFIA) regulates veterinary biologics and animal health products such as antibody products, vaccines, diagnostic kits that are used for the prevention, treatment and diagnosis of infectious diseases in animals.

Other major market players in cattle biologics market include Addison Cattle Corporation, Agrilabs, Biocor Animal Health, Inc., Boehringer Ingelheim, Colorado Serum Company, Durvet, Inc., Fort Dodge Animal Health, Merial, Novartis AG and Pfizer, Inc.

Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=3608&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes

markengine-blog · 7 years

Text

The Golabl Bovine Respiratory Disease Treatment Market Industry Analysis

Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. However, due to increasing consumption of milk and beef products, the need for bovine respiratory disease treatment has increased across the globe.

Request For Sample Report : http://www.mrrse.com/sample/2191

Moreover, according to the World Bank Group (2016), global human population is estimated to be 7.4 billion in 2016 and is growing at a rate of 1.8% per year. Hence, demand for beef has increased due to rising population and increasing disposable income across the world. The rising demand for high quality bovine derived products is influencing the bovine respiratory disease treatment market. Despite of innovations in veterinary medicines and advancement in technology, bovine respiratory disease is the leading cause to impact negatively on both the dairy and beef industries due to calf mortality, additional labor cost and treatment expenses. Moreover, bovine respiratory disease affects adversely on reproductive performance, growth and longevity of cattle. Hence, prevention and treatment of bovine respiratory disease have become important to decrease the impact on animal production and the beef industry. Therefore, the bovine respiratory disease treatment market is anticipated to witness significant growth in terms of revenue during the forecast period.

Global Bovine Respiratory Disease Treatment Market: Segmentation

In terms of treatment type, the bovine respiratory disease treatment market has been categorized into vaccines, antibiotics, NSAIDs, and immunomodulators. Causative agents such as viruses leading to bovine respiratory disease have no direct treatment. Hence, vaccination is the preferred choice of preventive action against the disease. This increase market potential for vaccines. However, virus infected cattle is exposed to bacteria, parasites, and various other factors. Therefore, antibiotics are the preferred choice of treatment for bovine respiratory diseases. Effective treatment and significant demand has increased the scope for antibiotics in the bovine respiratory disease treatment market.

However, according to NCBI report, combination treatment with anti-inflammatory drugs such as NSAIDs has better results over the monotherapy of antibiotics. This has led to increase in usage of NSAIDs in bovine respiratory disease treatment. Bovine respiratory disease is generally treated with several combination therapies. However, growing resistance to antibiotics and drying pipeline has increased demand for novel treatment options for which cattle do not develop resistance, and consequently there is no impact on human life.

Send An Enquiry : http://www.mrrse.com/enquiry/2191

Development of newer generation antibiotics for cattle is anticipated to drive the global bovine respiratory disease treatment market during the forecast period. In order to avoid the issue of antibiotics resistance in bovine population, preventive measures such as vaccination and immunomodulators has observed increased global acceptance against the bovine respiratory disease. Hence, preventive treatment is gaining momentum due to growing awareness about the negative impact of antibiotics on human health. This has driven the market for immunomodulators, vitamin injections, and other immunity building products.

In terms of disease type, the market has been segmented into upper respiratory tract infections, diphtheria, and pneumonia (lower respiratory tract infection). Upper respiratory tract infections dominated the global bovine respiratory disease market, accounting for significant share in terms of revenue in 2015. Respiratory infections first affect the upper respiratory tract, which is also the most vulnerable region, followed by other parts of the respiratory tract. Diphtheria accounted for significant share of the bovine respiratory disease treatment market in 2015. Pneumonia (lower respiratory tract infection) accounted for high market share, followed after upper respiratory tract infection in 2015. Hence, early detection of infection is important in bovine respiratory diseases treatment.

In terms of distribution channel, the global bovine respiratory disease treatment market has been segmented into veterinary hospitals, veterinary clinics, private veterinary pharmacies, and veterinary research institutes. Veterinary hospitals dominated the global bovine respiratory disease market in 2015. The segment dominated the market due to factors such as rising population of cattle which increases prevalence of bovine respiratory diseases. The private veterinary pharmacies distribution channel segment is projected to register significant CAGR during the forecast period. The segment is likely to witness strong growth in most of the emerging parts of the world and preference for medicines from private veterinary pharmacies for bovine serum respiratory diseases. However, the veterinary clinics and veterinary research institutes segments are expected to grow steadily as majority of procedures are carried out in veterinary hospitals.

Global Bovine Respiratory Disease Treatment Market: Geographical and Competitive Dynamics

Geographically, the bovine respiratory disease treatment market has been categorized in five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America held the major share of the global bovine respiratory disease treatment market in 2015, where the U.S. dominates the market in terms of revenue. Europe accounted for a significant share of the market in 2015. Changing environmental factors, growing prevalence of causative agents for respiratory disease, increasing demand for quality bovine products, and rising bovine population are the key factors driving the bovine respiratory disease treatment market in Europe. Asia Pacific is the largest producer of bovine livestock. Hence, it presents significant opportunities in the bovine respiratory disease treatment market. India and China are the key markets for bovine respiratory disease treatment, as these have largest livestock population compared to other countries across the globe. Latin America and Middle East & Africa have comparatively smaller markets for bovine respiratory disease treatment. However, Brazil, Mexico, and Argentina are the emerging markets in Latin America due to significant number of livestock population.

Brows Full Report With TOC : http://www.mrrse.com/bovine-respiratory-disease-treatment-market

Key players operating in the global bovine respiratory disease treatment market are Merck & Co., Inc., Zoetis Services LLC, Bayer AG, Elanco, Merial, Boehringer Ingelheim GmbH, Virbac Group, Ceva, Vetoquinol, and Bimeda Animal Health, among others.

The bovine respiratory disease treatment market has been segmented as follows:

Global Bovine Respiratory Disease Treatment Market, by Treatment Type

Vaccines

Antibiotics

NSAIDs

Immunomodulators

Others

Global Bovine Respiratory Disease Treatment Market, by Disease Type

Upper Respiratory Tract Infections

Diphtheria

Pneumonia (lower respiratory tract infection)

Global Bovine Respiratory Disease Treatment Market, by Distribution Channel

Veterinary Hospitals

Veterinary Clinics

Private Veterinary Pharmacies

Veterinary Research Institutes

Others

Global Bovine Respiratory Disease Treatment Market, by Geography

North America

Germany

Asia Pacific

Middle East & Africa

Latin America

Canada

Europe

France

Spain

Italy

Rest of Europe

China

Japan

India

Australia & New Zealand

Rest of APAC

Saudi Arabia

UAE

South Africa

North Africa

Rest of MEA

Brazil

Mexico

Rest of Latin America

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower 90, State Street Suite 700 Albany, NY - 12207 United States

Telephone: +1-518-730-0559 Email: [email protected]

Google+: https://plus.google.com/u/0/109558601025749677847/posts

Linked in: https://www.linkedin.com/company/mrrse

Twitter: https://twitter.com/MRRSEmrrse

0 notes

marketdataforecastblog-blog · 7 years

Text

Getting The Mortality Rate Down By Exploring The Treatment of the Bovine Respiratory Diseases

Bovine Respiratory Disease Treatment Market – Overview

There have been a number of studies to understand the Treatment of the Bovine Respiratory Disease that is done to assist the company executive and the industry participants to support them in making strategic initiatives and decisions that relate to the predictions of the treatment.

The study researches on the size of the market and the forecast and analysis the chief trends that are predominant in the worldwide market of the bovine respiratory disease treatment.

The disease is categorized by the disease type, type of treatment, the geographical distribution and the channel of distribution. Based on what the type of treatment is, the respiratory diseases handling market has been characterized under antibiotics, vaccines, respiratory upper tract and pneumonia.

When the bovine respiratory tracts are administered, the respiratory upper tract and pneumonia are the main disease types that are considered. In terms of the channel of distribution, the market has been characterized under research institutions, hospitals, and clinics.

The international respiratory bovine respiratory disease treatment market for treatment has been divided into major regions and chief regional level market which are, Europe, North America, Asia Pacific, Middle East, Latin America, and Africa.

The report studies the CAGRs for the period of forecast of 2016-2021, and there is a further cross-sectional study constructed on the type of treatment, distribution channel, and disease type and country level market. Market dynamics are also included to give an improved consideration of the current and the anticipated trends in the bovine treatment market.

The international market of the disease features a competitive consolidated landscape despite there being numerous regional players present. However owing to the small duration of product that is exclusive to the healthcare industry for animals. The competition from the over the counter goods is a huge threat.

There has been a massive upsurge in the growth of consumption of bovine products in the emerging economies like China, India, and Brazil. There has also been a rise in the demand for the effective treatment methods. There have been numerous establishments that have established operations in these countries.

It is estimated that the market has been projected at USD 24.5 million in the year 2016 and it is projected that it will touch USD 67.31 million by the year 2021.This is at a CAGR of 22,4% as per the period of forecast of 2016 to 2021. This has a lot of effect on the value of cattle in the marketplace.

The disease is affecting the cattle business and is costly and is also one of the popular illnesses in the cattle today. Bovine respiratory disease is a costly expense for those who own cattle, but it can be avoided by taking some vaccine. Early detection makes treatment easy and also successful and is thus highly recommended.

The disease has been classified as anti-infectious, oral rehydration and mucolytic. Antibiotics and anti-inflammatory drugs are being used for combination treatments to improve the rate of success of the treatment.

North America leads the market as it has the highest case of the respiratory bovine disease. In the Asia Pacific district, India and China have greater cattle adoption, and thus the disease is probable to rise faster here.

Studies show that the antibiotics in bovine can have an undesirable influence on humans. The interruption of the standard human intestinal flora and the initiation of antimicrobial bacteria resistant is believed to be observed in humans who take animal products with additional antibiotics. There have been reports of deaths and infections due to the consumption of these products. The factors have pushed the government to control the therapeutics antibiotic in animals also.

Check out Market Data Forecast’s comprehensive reports with in-depth analysis about the Bovine Respiratory Disease Treatment Market a free research sample can also be availed. Stay tuned for trending news stories about the latest technologies and interesting Healthcare tit-bits.

#Bovine Respiratory Diseases

0 notes

marketdataforecastblog-blog · 7 years

Text

Getting The Mortality Rate Down By Exploring The Treatment of the Bovine Respiratory Diseases

Bovine Respiratory Disease Treatment Market – Overview

The study researches on the size of the market and the forecast and analysis the chief trends that are predominant in the worldwide market of the bovine respiratory disease treatment.

#bovine respiratory disease treatment #healthcare

0 notes

healthy-insights · 8 years

Text

Bovine Respiratory Disease Treatment Market Research Report by Regional Analysis - North America, Europe, Asia Pacific, Latin America, Middle East & Africa : forecast 2024

Global Bovine Respiratory Disease Treatment Market: Overview

Treatment of Upper Respiratory Tract Infections to be Dominant Contributor to Market Revenue

In terms of disease type, upper respiratory tract infections dominated the global bovine respiratory disease treatment market, accounting for a share of over 50% in the global market terms of revenue in 2015. As the onset of most bovine respiratory infections begins from the upper respiratory tract, the segment is expected to emerge as the one with the most promising growth over the forecast period. TMR estimates that the segment will exhibit an 8.2% CAGR from 2016 through 2024. The segment of pneumonia (lower respiratory tract infection), which accounted for a share of 27.4% in the global market in terms of revenue in 2015, will also exhibit an equally promising but comparatively lower rate of growth over the forecast period.

Browse full report on Bovine Respiratory Disease Treatment Market -

http://www.transparencymarketresearch.com/bovine-respiratory-disease-treatment-market.html

Global Bovine Respiratory Disease Treatment Market: Segmentation

Global Bovine Respiratory Disease Treatment Market: Geographical and Competitive Dynamics

Request for sample of this report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13700

About Us

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes

healthy-insights · 8 years

Text

Global Bovine Respiratory Disease Treatment Market: Valuation to Nearly Double by 2024, predicts TMR

The global market for bovine respiratory disease treatment features a highly consolidated competitive landscape despite the presence of a large number of regional players, observes a recent report by Transparency Market Research. Owing to the small duration of product exclusivity in the animal health care industry – about three to five years - competition from generics and over-the-counter (OTC) products is a big threat.

The rising consumption of bovine products in emerging economies such as India, China, and Brazil, the demand for effective treatment methods for respiratory disease has considerably increased. To exploit the vast growth potential, an increasing number of companies are establishing operations in these countries. A recent example is the 2016 collaboration between Merial and Zoetis, Inc., which is expected to allow the former to effectively market and distribute its product in India. Some of the other key companies in the market are Merck & Co., Inc., Bayer AG, Elanco, Boehringer Ingelheim GmbH, and Virbac Group.

TMR estimates that the global bovine respiratory disease treatment market will exhibit a promising 7.6% CAGR from 2016 through 2024. At this rate, the market, which had a valuation of US$805.9 mn in 2015 is projected to reach US$1,543.9 mn by 2024.

Download Exclusive Brochure of This Report :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13700

Asia Pacific to Lead to Lucrative Growth Opportunities

In terms of distribution channel, the segment of veterinary hospitals dominated, accounting for nearly 35% of the global market in terms of revenue in 2015. From a geographic perspective, North America which held nearly 37% of the market in 2015, dominated the global market and is expected to easily retain its dominance over the forecast period as well. However, owing to the rising population of cattle and the rising incidences of bovine respiratory diseases, the Asia Pacific market will emerge as one of the most lucrative regional markets for bovine respiratory disease treatment methods.

Rising Consumption of Animal Protein to Remain High-impact Driver

Of the key factors driving the market, the rising consumption of beef is expected to have a prominent impact on the overall development of the market over the forecast period. According to a World Bank Group survey (2016), global human population is estimated to be 7.4 billion in 2016 and is growing at a rate of 1.8% per year. To sustain the ever rising demand for beef as well as other animal products from this mounting global population, there would be a vast rise in the world’s cattle population in the near future. According to the Food and Agriculture Organization (FAO), the global cattle population will increase by 73% between 2015 and 2050, from nearly 936 mn in 2015 to nearly 2.6 bn in 2050.

As bovine respiratory diseases account for 65% to 80% of morbidity and 45% to 75% mortality rate in livestock animals, the rising cattle population will also intensify the need for effective treatment modalities for these diseases. This will have a significant positive impact on the global bovine respiratory disease treatment market.

Strict Government Regulations to Restrain Market

Several studies have demonstrated that bovine antibiotics can have a highly negative impact on human health. Issues such as induction of antimicrobial-resistant bacteria and disruption of normal human intestinal flora are commonly observed in individuals who consume animal products with excessive amount of antibiotics. According to The New York Times, around 2 million people in the U.S. fall sick every year and about 23,000 of them die from antibiotic-resistant infections induced due to consumption of such products.

These factors have urged government bodies to regulate the use of antibiotic therapeutics in animals too. In December 2013, the Food and Drug Administration (FDA) enforced a new policy related to the limited use of antibiotics in production animals. This is likely to hamper the growth of the bovine respiratory disease treatment market over the forecast period.

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/bovine-respiratory-disease-treatment-market.html

This review of the market is based on a recent market research report published by TMR, titled “Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024.”

For the study, the market has been segmented as follows:

Global Bovine Respiratory Disease Treatment Market, by Treatment Type

Vaccines

Antibiotics

NSAIDs

Immunomodulators

Others

Global Bovine Respiratory Disease Treatment Market, by Disease Type

Upper Respiratory Tract Infections

Diphtheria

Pneumonia (lower respiratory tract infection)

Global Bovine Respiratory Disease Treatment Market, by Distribution Channel

Veterinary Hospitals

Veterinary Clinics

Private Veterinary Pharmacies

Veterinary Research Institutes

Others

Global Bovine Respiratory Disease Treatment Market, by Geography

North America

Germany

Asia Pacific

Middle East & Africa

Latin America

U.S.

Canada

Europe

U.K.

France

Spain

Italy

Rest of Europe

China

Japan

India

Australia & New Zealand

Rest of APAC

Saudi Arabia

UAE

South Africa

North Africa

Rest of MEA

Brazil

Mexico

Rest of Latin America

About Us

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com

0 notes